These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 29288113

  • 1. Early Botulinum Toxin Injections in Infants With Musculoskeletal Disorders: A Systematic Review of Safety and Effectiveness.
    Bourseul JS, Molina A, Lintanf M, Houx L, Chaléat-Valayer E, Pons C, Brochard S.
    Arch Phys Med Rehabil; 2018 Jun; 99(6):1160-1176.e5. PubMed ID: 29288113
    [Abstract] [Full Text] [Related]

  • 2. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
    Grigoriu AI, Dinomais M, Rémy-Néris O, Brochard S.
    Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
    [Abstract] [Full Text] [Related]

  • 3. The Effectiveness and Safety of Botulinum Toxin Injections for the Treatment of Congenital Muscular Torticollis.
    Qiu X, Cui Z, Tang G, Deng H, Xiong Z, Han S, Tang S.
    J Craniofac Surg; 2020 Nov; 31(8):2160-2166. PubMed ID: 33136847
    [Abstract] [Full Text] [Related]

  • 4. [Botulinum toxin treatment in children].
    Sätilä H, Vähäsarja V, Paavilainen P.
    Duodecim; 2011 Nov; 127(22):2417-24. PubMed ID: 22238919
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J, Hoare B, Wallen M.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD003469. PubMed ID: 15495055
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J, Hoare B, Wallen M.
    Cochrane Database Syst Rev; 2004 Oct 18; (3):CD003469. PubMed ID: 15266487
    [Abstract] [Full Text] [Related]

  • 7. Safety of botulinum toxin type A: a systematic review and meta-analysis.
    Naumann M, Jankovic J.
    Curr Med Res Opin; 2004 Jul 18; 20(7):981-90. PubMed ID: 15265242
    [Abstract] [Full Text] [Related]

  • 8. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E, Trevisi E, Martinuzzi A.
    Eur J Paediatr Neurol; 2016 Jul 18; 20(4):532-7. PubMed ID: 27177451
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES, Sonne-Holm S, Wong C, Curtis D, Bencke J.
    Ugeskr Laeger; 2015 Jan 12; 177(3):V07140409. PubMed ID: 25613095
    [Abstract] [Full Text] [Related]

  • 10. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials.
    Leonardi G, Alito A, Portaro S, Di Matteo B, Respizzi S, Kon E, Massazza G, Sconza C.
    Eur J Pain; 2024 Mar 12; 28(3):369-381. PubMed ID: 37950343
    [Abstract] [Full Text] [Related]

  • 11. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
    García Salazar LF, dos Santos GL, Pavão SL, Rocha NA, de Russo TL.
    Dev Neurorehabil; 2015 Feb 12; 18(1):1-14. PubMed ID: 25180438
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL, Klochkova OA, Bursagova BI, Karimova HM, Kuzenkova LM, Mamedyarov AM, Namazova-Baranova LS, Agranovich OV, Agranovich AO, Soboleva OA, Khapaeva MM, Batysheva TT, Sarzhina MN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017 Feb 12; 117(11):37-44. PubMed ID: 29265085
    [Abstract] [Full Text] [Related]

  • 13. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections.
    Lannin N, Scheinberg A, Clark K.
    Dev Med Child Neurol; 2006 Jun 12; 48(6):533-9. PubMed ID: 16700950
    [Abstract] [Full Text] [Related]

  • 14. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD.
    Clin Ther; 2007 Jul 12; 29(7):1325-37. PubMed ID: 17825685
    [Abstract] [Full Text] [Related]

  • 15. Indications and effects of botulinum toxin A for obstetric brachial plexus injury: a systematic literature review.
    Gobets D, Beckerman H, de Groot V, Van Doorn-Loogman MH, Becher JG.
    Dev Med Child Neurol; 2010 Jun 12; 52(6):517-28. PubMed ID: 20163432
    [Abstract] [Full Text] [Related]

  • 16. Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
    Albavera-Hernández C, Rodríguez JM, Idrovo AJ.
    Clin Rehabil; 2009 May 12; 23(5):394-407. PubMed ID: 19389744
    [Abstract] [Full Text] [Related]

  • 17. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
    Boyd RN, Hays RM.
    Eur J Neurol; 2001 Nov 12; 8 Suppl 5():1-20. PubMed ID: 11851730
    [Abstract] [Full Text] [Related]

  • 18. Sonography-guided injection of botulinum toxin A in children with cerebral palsy.
    Berweck S, Feldkamp A, Francke A, Nehles J, Schwerin A, Heinen F.
    Neuropediatrics; 2002 Aug 12; 33(4):221-3. PubMed ID: 12368994
    [Abstract] [Full Text] [Related]

  • 19. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
    Bradley LJ, Huntley JS.
    Arch Dis Child; 2014 Apr 12; 99(4):392-4. PubMed ID: 24626322
    [No Abstract] [Full Text] [Related]

  • 20. Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?
    Wasiak J, Hoare BJ, Hender KM.
    Med J Aust; 2002 Aug 05; 177(3):158. PubMed ID: 12149089
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.